New Lung Cancer Screening Guidelines Expand Recommended Use of Low-Dose CT

Share this content:

(ChemotherapyAdvisor) – The American Association for Thoracic Surgery (AATS) has issued guidelines for lung cancer screening using low-dose computed tomography scans for groups at high risk of developing lung cancer and survivors of lung cancer. The guidelines were published in the July 2012 issue of the Journal of Thoracic and Cardiovascular Surgery.

The 14-member task force—which includes thoracic surgeons, thoracic radiologists, medical oncologists, a pulmonologist, a pathologist, and an epidemiologist—that created the guidelines recommends annual lung cancer screening using low-dose computed tomography for:

  • Current and former smokers aged 55 to 79 years with a 30 pack-year history of smoking
  • Current and former smokers aged 50 to 79 years with a 20 pack-year history if there is an additional cumulative risk of developing lung cancer of 5% or greater over the following 5 years
  • Long-term lung cancer survivors until age 79 years (to detect second primary lung cancer)

These guidelines differ from those of other societies in that they recommend screening for patients up to the age of 79—vs 74—years and also address lung cancer survivors. Using the AATS recommendations, 94 million Americans are now eligible for screening, which requires participation by a subspecialty-qualified team, the study noted.

The AATS task force does not recommend screening for individuals with conditions that would preclude successful treatment for lung cancer. The AATS plans to continue to engage with other specialty societies to refine future screening guidelines.

Abstract

Related Resources

You must be a registered member of Cancer Therapy Advisor to post a comment.

Sign Up for Free e-newsletters



Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs